Author
Andrew R. Pachner
Also Known As
A R Pachner, A. Pachner, A. R. Pachner, A.R. Pachner, ANDREW R. PACHNER, Andrew R. Pachner, Andrew Pachner, Andrew R Pachner, Andrew R. Pachner, Andrew Rudolf Pachner
194
Publications
7.7K
Citations
43
H-Index
119
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 32 | 52 | 3.8K |
2 | Allergy | 14 | 14 | 444 |
3 | Health Sciences | 8 | 8 | 1.1K |
4 | Social Sciences | 2 | 2 | 101 |
5 | Public Health | 1 | 1 | 52 |
Andrew R. Pachner
×
79
Publications
5.6K
Citations
37
H-Index
| Year | Citations | |
|---|---|---|
2018 | 896 | |
1985 | 580 | |
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension Raju Kapoor, Pei‐Ran Ho, Nolan Campbell, Disease ProgressionNeurological DisorderImmunologyClinical TrialsNeurology | 2018 | 327 |
1985 | 246 | |
2010 | 199 | |
2009 | 185 | |
1989 | 175 | |
2005 | 142 | |
2000 | 121 | |
1990 | 118 |
Page 1
Page 1